Syros Pharmaceuticals Inc. (SYRS) gains 2.24% for July 21

Equities Staff  |

Syros Pharmaceuticals Inc. (NASDAQ: SYRS) shares gained 2.24%, or $0.11 per share, to close Wednesday at $5.03. After opening the day at $4.88, shares of Syros fluctuated between $5.06 and $4.75. 436,530 shares traded hands a decrease from their 30 day average of 917,364. Wednesday's activity brought Syros’s market cap to $311,147,083.

Syros is headquartered in Cambridge, Massachusetts..

About Syros Pharmaceuticals Inc.

Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches. Syros is advancing a robust clinical-stage pipeline, including: SY-1425, a first-in-class oral selective RAR? agonist in RARA-positive patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide in patients with acute promyelocytic leukemia; and SY-5609, a highly selective and potent oral CDK7 inhibitor in patients with select solid tumors. Syros also has multiple preclinical and discovery programs in oncology and monogenic diseases.

Visit Syros Pharmaceuticals Inc.’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Syros Pharmaceuticals Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: Syros Pharmaceuticals Inc.’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content